Wu Tsu-Lan, Chia Ju-Hsin, Kuo An-Jing, Su Lin-Hui, Wu Ting-Shu, Lai Hsin-Chih
Department of Medical Biotechnology and Laboratory Science, Chang Gung University, No. 259, Wen-Hua 1st Road, Kwei-Shan, Tao-Yuan 333, Taiwan, Republic of China.
J Clin Microbiol. 2008 Nov;46(11):3591-4. doi: 10.1128/JCM.00856-08. Epub 2008 Sep 3.
The rapid identification of mycobacteria from smear-positive sputum samples is an important clinical issue. Furthermore, the availability of a cheap, technically simple, and accurate method also would benefit mycobacterial laboratories in developing countries. In the present study, we aimed to develop an assay allowing the identification of the Mycobacterium tuberculosis complex (MTBC) and other frequently isolated nontuberculous mycobacteria (NTM) directly from smear-positive sputum samples. A nested PCR-restriction fragment length polymorphism analysis (nested-PRA) assay that focuses on the analysis of the hsp65 gene was developed and evaluated for its efficiency compared to that of traditional culture methods and 16S rRNA gene sequencing identification. A total of 204 smear-positive and culture-positive sputum specimens were prospectively collected for analysis between November 2005 and May 2006. The samples were classified according to an acid-fast bacillus (AFB) staining scale as rare/1+, 2+, or 3+. The results of the nested-PRA showed that the identification rate for AFB 3+, AFB 2+, and AFB rare/1+ samples was 100, 95, and 53%, respectively, and that the overall identification rate was 89%. All positive results by the nested-PRA method agreed with the results by culture and 16S rRNA gene sequence analysis. The nested-PRA appears to have clinical applicability when used for the direct identification of mycobacterial organisms (both MTBC and NTM) that are present in smear-positive sputum samples, especially for countries in which MTBC is endemic.
从涂片阳性痰标本中快速鉴定分枝杆菌是一个重要的临床问题。此外,拥有一种廉价、技术简单且准确的方法也将使发展中国家的分枝杆菌实验室受益。在本研究中,我们旨在开发一种检测方法,能够直接从涂片阳性痰标本中鉴定结核分枝杆菌复合群(MTBC)和其他常见的非结核分枝杆菌(NTM)。我们开发了一种基于hsp65基因分析的巢式PCR-限制性片段长度多态性分析(巢式-PRA)检测方法,并与传统培养方法和16S rRNA基因测序鉴定方法相比,评估了其效率。2005年11月至2006年5月期间,前瞻性收集了204份涂片阳性且培养阳性的痰标本进行分析。根据抗酸杆菌(AFB)染色程度将样本分为罕见/1+、2+或3+。巢式-PRA结果显示,AFB 3+、AFB 2+和AFB罕见/1+样本的鉴定率分别为100%、95%和53%,总体鉴定率为89%。巢式-PRA方法的所有阳性结果均与培养及16S rRNA基因序列分析结果一致。当用于直接鉴定涂片阳性痰标本中存在的分枝杆菌(MTBC和NTM)时,巢式-PRA似乎具有临床适用性,尤其对于MTBC为地方病的国家。